Article Text
Therapeutics
Self-monitoring of blood glucose was not cost-effective in non–insulin-treated type 2 diabetes
Statistics from Altmetric.com
J Simon
Dr J Simon, University of Oxford, Oxford, UK; judit.simon@dphpc.ox.ac.uk
STUDY DESIGN
Design:
cost-effectiveness analysis of a randomised controlled trial with 1-year follow-up (Diabetes Glycaemic Education and Monitoring [DiGEM]).
STUDY QUESTION
Setting:
48 general practices in the UK.
Patients:
453 patients {mean age 66 y, 57% men}* who had non–insulin-treated type 2 diabetes with haemoglobin (Hb) A1c concentrations ⩾6.2% and were not self-monitoring glucose. {Exclusion criteria included serious …
Footnotes
Source of funding: UK NHS and NHS Health Technology Assessment Programme.